Filing Details
- Accession Number:
- 0001209191-21-029341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-30 13:00:00
- Reporting Period:
- 2021-04-28
- Accepted Time:
- 2021-04-30 17:49:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1348911 | Kalvista Pharmaceuticals Inc. | KALV | Pharmaceutical Preparations (2834) | 200915291 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1777800 | David Michael Smith | C/O Kalvista Pharmaceuticals, Inc 55 Cambridge Parkway, Suite 901E Cambridge MA 02142 | Senior Vp, Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-28 | 10,014 | $8.39 | 10,014 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-04-28 | 10,014 | $25.76 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-04-28 | 10,014 | $0.00 | 10,014 | $8.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,096 | 2026-11-21 | No | 4 | M | Direct |
Footnotes
- The option is fully vested.